18 August 2026

PBAC PBS Pharmaceuticals

PBAC nod for unrestricted triptorelin access

13 August 2026

Diabetes PBS Pharmaceuticals

Butler vows to get GLP-1s on PBS, ‘one way or the other’

13 August 2026

Biosimilars PBS Pharmaceuticals

GBMA targets medicine shortages

6 August 2026

Biologics Gastroenterology IBD PBS Pharmaceuticals

IBD patients caught in Australia’s medicines access gap

17 July 2026

federal government PBAC PBS Pharmaceuticals

PBS reprieve for MS blockbusters

16 July 2026

Breast cancer Clinical PBS

AstraZeneca announces new access program for cancer implant

7 July 2026

PBS Pharmaceuticals Rheumatology

Another myasthenia gravis add-on given PBS listing

3 July 2026

Addiction PBS Pharmaceuticals

‘Commercial decision’ to withdraw opioid addiction treatment

2 July 2026

Allergies PBS

Intranasal adrenaline added to PBS

2 July 2026

PBS Pharmaceuticals TheHill

PBS future of two leading MS therapies hangs on pricing decision

8 June 2026

Migraine PBS

Relief for migraine sufferers in latest PBS changes

19 May 2026

PBS Pharmaceuticals Technology

PBS ‘cannot stand still’ as US drives drug pricing reform

11 May 2026

PBS Pharmaceuticals

Three lamotrigine brands given Restricted Benefit listing

23 April 2026

Clinical PBS Pharmaceuticals

Aussie-made hereditary angioedema therapy gains PBS listing

7 April 2026

PBS Rheumatology

Yet another myasthenia gravis treatment added to PBS

30 March 2026

Cancer Government PBS

PBS expands pembrolizumab access for three cancers